Protein Expression Market Size, Share, Growth, Emerging Trends, Top 10 Players and Industry Outlook

 Key Factors Driving Market Growth:

The growth of protein expression market is driven majorly by the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics. Emerging economies are likely to create significant growth opportunities for players in the market.

Revenue Growth Analysis:

[173 Pages Report] The global protein expression market size is projected to reach USD 4.1 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 13.2%

The study involved four major activities in estimating the current size for protein expression market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180323924

Therapeutic applications held the largest share of the protein expression market

Based on the applications, the protein expression industry is segmented into therapeutic, industrial, and research. Therapeutic applications accounted for the largest share of this market in 2019. The growth of this segment is attributed to the rising incidences of the disease and growing R&D activity. The large share of this segment can be attributed to an increase in proteomics-based research and the rising prevalence of chronic diseases across the globe.

The reagents segment accounted for the largest share of the protein expression industry in 2019.

Based on product and service, the protein expression industry is segmented into reagents, expression vectors, competent cells, instruments, and services. The reagents segment accounted for the largest share of the market in 2019. The large share of this segment is mainly due to the increasing research activities in the field of protein expression and the large-scale production of antibodies and vaccines.

The Asia Pacific protein expression market is expected to grow at the highest CAGR

Asia Pacific is expected to grow at the highest rate in the market. The major factors driving the growth of this market include high incidence of chronic diseases, increasing public and private investments, and increase in life sciences research.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=180323924

North America dominated the protein expression sector, followed by Europe. The major factors driving the growth of this market include the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics.

Key Players:

The prominent players in the global protein expression market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Genscript Biotech Corporation (US), Takara Bio, Inc. (Japan), Bio-Rad Laboratories (US), Lonza (US), Promega Corporation (US), New England Biolabs (US), Oxford Expression Technologies Ltd. (US), and Synthetic Genomics Inc. (US).

Thermo Fisher Scientific Inc. is the largest player in the protein expression market. The large share of this company can be attributed to its strong suite of expression vectors, reagents, competent cells, and instruments. Owing to its strong sales and distribution network, the company has a significant global footprint. Additionally, the large number of production sites give it a competitive advantage over other players in the market.

The company focuses on product launches to create a strong foothold in the market. In 2018, Thermo Fisher Scientific Inc. launched the Gibco ExpiSf System, the first-ever chemically defined protein expression system. The company further intends to strengthen its presence in this market by investing in R&D. Its extensive R&D activities enable it to increase its depth of capabilities in protein expression solutions and services and to provide innovative products and services in the protein expression market space.

Key Factors Driving Market Growth:

The growth of protein expression market is driven majorly by the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics. Emerging economies are likely to create significant growth opportunities for players in the market.

Revenue Growth Analysis:

[173 Pages Report] The global protein expression market size is projected to reach USD 4.1 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 13.2%

The study involved four major activities in estimating the current size for protein expression market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180323924

Therapeutic applications held the largest share of the protein expression market

Based on the applications, the protein expression industry is segmented into therapeutic, industrial, and research. Therapeutic applications accounted for the largest share of this market in 2019. The growth of this segment is attributed to the rising incidences of the disease and growing R&D activity. The large share of this segment can be attributed to an increase in proteomics-based research and the rising prevalence of chronic diseases across the globe.

The reagents segment accounted for the largest share of the protein expression industry in 2019.

Based on product and service, the protein expression industry is segmented into reagents, expression vectors, competent cells, instruments, and services. The reagents segment accounted for the largest share of the market in 2019. The large share of this segment is mainly due to the increasing research activities in the field of protein expression and the large-scale production of antibodies and vaccines.

The Asia Pacific protein expression market is expected to grow at the highest CAGR

Asia Pacific is expected to grow at the highest rate in the market. The major factors driving the growth of this market include high incidence of chronic diseases, increasing public and private investments, and increase in life sciences research.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=180323924

North America dominated the protein expression sector, followed by Europe. The major factors driving the growth of this market include the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics.

Key Players:

The prominent players in the global protein expression market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Genscript Biotech Corporation (US), Takara Bio, Inc. (Japan), Bio-Rad Laboratories (US), Lonza (US), Promega Corporation (US), New England Biolabs (US), Oxford Expression Technologies Ltd. (US), and Synthetic Genomics Inc. (US).

Thermo Fisher Scientific Inc. is the largest player in the protein expression market. The large share of this company can be attributed to its strong suite of expression vectors, reagents, competent cells, and instruments. Owing to its strong sales and distribution network, the company has a significant global footprint. Additionally, the large number of production sites give it a competitive advantage over other players in the market.

The company focuses on product launches to create a strong foothold in the market. In 2018, Thermo Fisher Scientific Inc. launched the Gibco ExpiSf System, the first-ever chemically defined protein expression system. The company further intends to strengthen its presence in this market by investing in R&D. Its extensive R&D activities enable it to increase its depth of capabilities in protein expression solutions and services and to provide innovative products and services in the protein expression market space.